Year 2012 Vol. 20 No 1




SEE HPE I.M.Sechenov First Moscow Medical University 1,
The Russian Federation
EE Vitebsk State Medical University2,
the Republic of Belarus

Objectives. To study the influence of the preparation of omega-3 fatty acids Omegaven on protein-lipid parities and phospholipid spectrum of mitochondrion membranes of the liver at the experimental widespread purulent peritonitis.
Methods. The research has been performed on 40 rabbits-males of chinchilla breed. Influence of the preparation of omega-3 fatty acids Omegaven on protein-lipid parities and phospholipid spectrum of mitochondrion membranes of the liver at the experimental widespread purulent peritonitis has been studied for the first time.
Results. The development of the widespread purulent peritonitis is characterized by the expressed imbalance of protein-lipid parities and phospholipid spectrum of mitochondrion membranes of the liver which is revealed through the percentage growth of lisophosphatides, possessing damaging action, and compensative activation of the systems restoring damages of mitochondrial membranes, at the expense of cardiolipin content increase.
Conclusions. It has been established that in the postoperative period Omegaven influences effectively phospholipid structure of mitochondrion by percentage decrease of lisophosphatides, level increase of polyglycerophosphatide and cardiolipin. The preparation prevents decrease in the amount of total phospholipids in mitochondrion membranes that together with stimulation of protein amount growth testifies to high protective properties of the preparation.

Keywords: widespread purulent peritonitis, Omegaven, mitochondria, phospholipids, cardiolipin, cholesterol
p. 10 -15 of the original issue

1.Eriukhin IA, Shliapnikov SA, Efimova IS. Peritonit i abdominal'nyi sepsis [Peritonitis and abdominal sepsis]. Infektsii v Khirurgii. 2004;(2):28.
2.Zavada NV, Gain IuM, Alekseev SA. Khirurgicheskii sepsis. Uchebnoe posobie [Surgical sepsis. Textbook]. Minsk, RB: Novoe znanie; 2003. 237 p.
3.Savel'ev VS, Gel'fand BR, Filimonov MI, editors. Peritonit: prakticheskoe rukovodstvo [Peritonitis: a practical guide]. Moscow, RF: Litterra; 2006. 208 p.
4. Popova TS. Nutritivnaia podderzhka bol'nykh v kriticheskikh sostoianiiakh [Nutritional support in critically ill patients]. Moscow, RF: M-Vesti; 2002; 319 p.
5.Meerson F3, Pshennikova MG. Adaptatsiia k stressornym situatsiiam i fizicheskim nagruzkam [Adaptation to the stress situations and physical loads]. Moscow, RF: Meditsina; 1988. 256 p.
6.Montero J, Mari M, Colell A, Morales A, Basanez G, Garcia-Ruiz C, Fernandez-Checa JC. Cholesterol and peroxidized cardiolipin in mitochondrial membrane properties, permeabilization and cell death. Biochim Biophys Acta. 2010:1797(6):121724.
7.Crouser ED, Julian MW, Blaho DV, Pfeiffer DR. Endotoxin-induced mitochondrial damage correlates with impaired respiratory activity. Crit Care Med. 2002;30:27684.
8.Chicco A, Sparagna G. Role of cardiolipin alterations in mitochondrial dysfunction and disease. Am J Physiol Cell Physiol. 2007;292:C33C44.
9. Ott M, Robertson JD, Gogvadze V, Zhivotovsky B, Orrenius S. Cytochrome c release from mitochondria proceeds by a two-step process. Proc Natl Acad Sci (USA). 2002;99(3):125963.
10.Calder PC. Long-chain n-3 fatty acids and inflammation: potential application in surgical and trauma patients. Braz J Med Biol Res. 2003;36:43346.
11.Heller A, Koch T, Schmeck J, van Ackern K. Lipid mediators in inflammatory disorders. Drugs. 1998;55(4):48796.
12.Mayer K, Gokorsch S, Fegbeutel C, Hattar K, Rosseau S, Walmrath D, Seeger W, Grimminger F. Parenteral nutrition with fish oil modulate cytokine response in patients with sepsis. Am J Respir Crit Care Med. 2003;167(10):132128.
13.Valentine RC, Valentine DL. Omega-3 fatty acids in cellular membranes: a unified concept. Prog Lipid Res. 2004;43:383402.
14. Johnson D, Lardy H. Methods Enzymol. 1967;10:9496.
15.Keits M. Tekhnika lipidologii [Technique of lipidology]. Moscow, RF: Mir; 1975;76:13840, 31011.
16.Pokrovskii AA. Biokhimicheskie metody issledovaniia [Biochemical methods of study]. Moscow, RF: Meditsina; 1969. 477p.
17.Svanborg A, Svennercholm L. Plasma total lipid cholesterol, triglycerides, phospholipids and free acids in a healthy scandinavian men. Acta Med Scand. 1961;169:43-46.
18.Vaskovsky VE, Kostetsky EJ, Vassenolin JM. A universal reagent for phospholipid analysis. J Chromatogr. 1975;114:12941.
19.Gornall AC, Bardawill CJ, David MM. Determination of serum proteins by means of the biuret reaction. J Biol Chem. 1949;177:75166.
20.Shimoji M, Imaizumi N, Aniya Y. Modulation of membrane-bound glutathione transferase activity by phospholipids including cardiolipin. Biol Pharm Bull. 2011;34:20913.
21.Orrenius S, Zhivotovsky B, Nicotera P. Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol. 2003;14:55265.
22. Schlame M, Rua D, Greenberg ML. The biosynthesis and functional role of cardiolipin. Prog Lipid Res. 2000;39:257288.
23. Lutter M, Fang M, Luo X, Nishijima M, Xie X, Wang X. Cardiolipin provides specificity for targeting of tBid to mitochondria. Nat Cell Biol. 2000;(2):75461.
24.Lowes DA, Thottakam BM, Webster NR, Murphy MP, Galley HF. The mitochondria-targeted antioxidant MitoQ protects against organ damage in a lipopolysaccharide-peptidoglycan model of sepsis. Free Radic Biol Med. 2008; 45(11):155965.
25.Preobrazhenskii NA, Evstigneeva RP. Khimiia biologicheski aktivnykh prirodnykh soedinenii [Chemistry of biologically active natural compounds]. Moscow, RF: Khimiia; 1976. 458 p.
26.Seleznev K. Calcium-independent phospholipase A2 localizes in and protects mitochondria during apoptotic induction by staurosporine. J Biol Chem. 2006;281:227588.

Address for correspondence:
119991, Rossiiskaia Federatsiia, g. Moskva, ul. Iauzskaia, d. 11, GOU VPO Pervyi Moskovskii gosudarstvennyi meditsinskii universitet im. I.M. Sechenova, kafedra obshchei khirurgii,
Kosinets Vladimir Aleksandrovich
Information about the authors:
Kosinets V.A. Candidate of medical sciences, applicant for Doctors degree of the chair of general surgery of I.M. Sechenov First Moscow State Medical University.
Osochuk S.S. Doctor of medical sciences, Associate Professor, head of the central scientific research laboratory of EE Vitebsk State Medical University.
Yarotskaya N.N. junior scientific researcher of the central scientific research laboratory of EE Vitebsk State Medical University.
Contacts | ©Vitebsk State Medical University, 2007-2023